Option Care Health, Inc.
OPCH
Pozycja w akcjach
#3634
Option Care Health, Inc. delivers infusion services to patients in their homes... Option Care Health, Inc. delivers infusion services to patients in their homes and other non-hospital settings throughout the United States. The company offers a broad spectrum of specialized infusion treatments, including therapies for various infections, management of heart failure, and comprehensive nutritional support (both intravenous and tube feeding) for individuals with acute or chronic conditions such as stroke, cancer, and digestive illnesses. They also provide immunoglobulin infusions for immune system deficiencies and treatments targeting chronic inflammatory disorders like Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, and ulcerative colitis. Furthermore, Option Care Health assists in managing the progression of neurological conditions such as amyotrophic lateral sclerosis (ALS) and Duchenne muscular dystrophy. They also administer infusion therapies for bleeding disorders and provide crucial support for women experiencing high-risk pregnancies. Other specialized infusion services encompass pain relief, chemotherapy, and respiratory care. Complementing these medical offerings, the company provides professional nursing services. Option Care Health, Inc. maintains its primary corporate office in Bannockburn, Illinois.
Cena akcji
$31.21
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$4.67B
Zmiana (1 dzień)
-0.05%
Zmiana (1 rok)
12.37%
Kraj
US
Handel Option Care Health, Inc. (OPCH)
Kategoria
Healthcare
Marża operacyjna dla Option Care Health, Inc. (OPCH)
Marża operacyjna na dzień October 2026 TTM: 5.94%
Według najnowszych raportów finansowych i ceny akcji Option Care Health, Inc., bieżąca marża operacyjna (TTM) wynosi 5.94%. Na koniec 2023 wynosiła 7.31%.
Historia marży operacyjnej dla Option Care Health, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 5.94% | -7.76% |
| 2024 | 6.44% | -11.90% |
| 2023 | 7.31% | 20.03% |
| 2022 | 6.09% | 9.73% |
| 2021 | 5.55% | 52.05% |
| 2020 | 3.65% | -2,021.05% |
| 2019 | -0.19% | -97.39% |
| 2018 | -7.28% | -497.81% |
| 2017 | 1.83% | 134.62% |
| 2016 | 0.78% | -102.66% |
| 2015 | -29.29% | 216.31% |
| 2014 | -9.26% | 1,015.66% |
| 2013 | -0.83% | -141.29% |
| 2012 | 2.01% | -21.18% |
| 2011 | 2.55% | 165.63% |
| 2010 | 0.96% | -17.24% |
| 2009 | 1.16% | -80.54% |
| 2008 | 5.96% | 705.41% |
| 2007 | 0.74% | -47.52% |
| 2006 | 1.41% | -48.16% |
| 2005 | 2.72% | 39.49% |
| 2004 | 1.95% | -28.31% |
| 2003 | 2.72% | -35.08% |
| 2002 | 4.19% | 25.83% |
| 2001 | 3.33% | 6,560.00% |
| 2000 | 0.05% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 15.48% | -97.39% |
US
|
|
| 0.00% | - |
DE
|
|
| 16.80% | -97.17% |
US
|
|
| 18.67% | -96.86% |
SA
|
|
| 0.00% | - |
MY
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.